[go: up one dir, main page]

NO20015722L - Antibakterielle forbindelser - Google Patents

Antibakterielle forbindelser

Info

Publication number
NO20015722L
NO20015722L NO20015722A NO20015722A NO20015722L NO 20015722 L NO20015722 L NO 20015722L NO 20015722 A NO20015722 A NO 20015722A NO 20015722 A NO20015722 A NO 20015722A NO 20015722 L NO20015722 L NO 20015722L
Authority
NO
Norway
Prior art keywords
antibacterial compounds
antibacterial
compounds
Prior art date
Application number
NO20015722A
Other languages
English (en)
Other versions
NO20015722D0 (no
Inventor
William H Miller
Kenneth Allen Newlander
Mark Seefeld
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20015722L publication Critical patent/NO20015722L/no
Publication of NO20015722D0 publication Critical patent/NO20015722D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20015722A 1999-06-01 2001-11-23 Antibakterielle forbindelser NO20015722D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13700499P 1999-06-01 1999-06-01
PCT/US2000/015154 WO2000072846A1 (en) 1999-06-01 2000-06-01 Antibacterial compounds

Publications (2)

Publication Number Publication Date
NO20015722L true NO20015722L (no) 2001-11-23
NO20015722D0 NO20015722D0 (no) 2001-11-23

Family

ID=22475391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015722A NO20015722D0 (no) 1999-06-01 2001-11-23 Antibakterielle forbindelser

Country Status (23)

Country Link
US (2) US6573272B1 (no)
EP (1) EP1180030B1 (no)
JP (1) JP4733836B2 (no)
KR (1) KR20020005767A (no)
CN (1) CN1365280A (no)
AR (1) AR024158A1 (no)
AT (1) ATE283049T1 (no)
AU (1) AU773550B2 (no)
BR (1) BR0011121A (no)
CA (1) CA2375630A1 (no)
CO (1) CO5370679A1 (no)
CZ (1) CZ20014290A3 (no)
DE (1) DE60016198T2 (no)
HK (1) HK1045644A1 (no)
HU (1) HUP0201206A3 (no)
IL (1) IL146514A0 (no)
MX (1) MXPA01012326A (no)
NO (1) NO20015722D0 (no)
NZ (1) NZ515611A (no)
PL (1) PL351959A1 (no)
TR (1) TR200103485T2 (no)
WO (1) WO2000072846A1 (no)
ZA (1) ZA200109733B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
AR024158A1 (es) 1999-06-01 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
AU7866300A (en) * 1999-10-08 2001-04-23 Smithkline Beecham Corporation Fab i inhibitors
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
PE20010635A1 (es) * 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
US6730684B1 (en) * 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
EP1347759B1 (en) * 2000-12-08 2005-06-29 Smithkline Beecham Corporation Antibacterial compounds
WO2002049576A2 (en) * 2000-12-21 2002-06-27 Rima Mcleod Fab i and inhibition of apicomplexan parasites
ES2248412T3 (es) * 2001-02-12 2006-03-16 Lilly Icos Llc Derivados de carbolina.
AU2002367773A1 (en) * 2001-04-06 2003-11-03 Affinium Pharmaceuticals, Inc. Fab i inhibitors
SI1575951T1 (sl) * 2002-12-06 2014-10-30 Debiopharm International Sa Forum "Apres-Demain" Heterociklične spojine, postopki za njihovo izdelavo in njihova uporaba v terapiji
ATE409485T1 (de) * 2003-03-17 2008-10-15 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
US20060273819A1 (en) * 2003-04-29 2006-12-07 Timothy Opperman Antibiotic tetrahydro-beta-carboline derivatives
US8450307B2 (en) * 2004-06-04 2013-05-28 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
JP2009518399A (ja) * 2005-12-05 2009-05-07 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉ阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
JP5468899B2 (ja) * 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
US7854963B2 (en) * 2006-10-13 2010-12-21 Solopower, Inc. Method and apparatus for controlling composition profile of copper indium gallium chalcogenide layers
EP3255045A1 (en) * 2007-02-16 2017-12-13 Debiopharm International SA Salts, prodrugs and polymorphs of fab i inhibitors
US8124616B2 (en) 2007-11-30 2012-02-28 Biota Scientific Management Pty Ltd Bicyclic PPAT inhibitors as antibacterial agents
KR101135179B1 (ko) * 2009-02-20 2012-04-16 한국생명공학연구원 ＦａｂＩ 저해 물질 비나산손을 포함하는 항균용 조성물
WO2012127885A1 (ja) 2011-03-18 2012-09-27 小野薬品工業株式会社 テトラヒドロカルボリン誘導体
MY170437A (en) 2012-06-19 2019-07-31 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
PL3419628T3 (pl) 2016-02-26 2021-05-31 Debiopharm International Sa Lek do leczenia zakażeń stopy cukrzycowej
CN112654354A (zh) * 2018-08-16 2021-04-13 菲尼克思药业股份有限公司 1,3,4,9-四氢-2H-吡啶并[3,4-b]吲哚衍生物化合物及其用途
HRP20230437T1 (hr) 2019-02-14 2023-07-07 Debiopharm International S.A. Formulacija afabicina, postupak izrade iste
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828068A (en) 1971-05-10 1974-08-06 Tenneco Chem ((substituted indazolyl)-n1-methyl)carbamates
US4154943A (en) 1977-12-29 1979-05-15 University Of Vermont Preparation of vincadifformine
US4267330A (en) * 1978-08-24 1981-05-12 Omnium Chimique Societe Anonyme Process for the synthesis of vincadifformine and related derivatives
FR2619111B1 (fr) 1987-08-07 1991-01-11 Synthelabo Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5416193A (en) * 1993-04-30 1995-05-16 Pfizer Inc. Coupling reagent and method
MA23420A1 (fr) 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US5614551A (en) 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
BR9508178A (pt) 1994-06-29 1997-11-18 Smithkline Beecham Corp Antagonistas de receptor de vitronectina
US6451816B1 (en) 1997-06-20 2002-09-17 Klinge Pharma Gmbh Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
DE19624659A1 (de) 1996-06-20 1998-01-08 Klinge Co Chem Pharm Fab Neue Pyridylalken- und Pyridylalkinsäureamide
JPH10310582A (ja) * 1997-03-13 1998-11-24 Sankyo Co Ltd ピペリジン環縮合カルバペネム化合物
JP2001518094A (ja) 1997-03-31 2001-10-09 デュポン ファーマシューティカルズ カンパニー Ｈｉｖプロテアーゼ阻害剤として有用なインダゾール−環式尿素
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US5932743A (en) 1997-08-21 1999-08-03 American Home Products Corporation Methods for the solid phase synthesis of substituted indole compounds
ES2241194T3 (es) * 1997-12-24 2005-10-16 Aventis Pharma Deutschland Gmbh Derivados de indol en calidad de inhibidores de factor xa.
ES2237966T3 (es) * 1998-08-20 2005-08-01 Agouron Pharmaceuticals, Inc. Agentes de gnrh no peptidicos, metodos y compuestos intermedios para su preparacion.
GT199900167A (es) * 1998-10-01 2001-03-21 Nuevos bis-benzimidazoles.
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
AR024077A1 (es) 1999-05-25 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
AR024158A1 (es) 1999-06-01 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
CO5180605A1 (es) 1999-06-23 2002-07-30 Smithkline Beecham Corp Compuestos de indol
US6346391B1 (en) 1999-07-22 2002-02-12 Trustees Of Tufts College Methods of reducing microbial resistance to drugs
WO2001026654A1 (en) 1999-10-08 2001-04-19 Smithkline Beecham Corporation Fab i inhibitors
AU7866300A (en) 1999-10-08 2001-04-23 Smithkline Beecham Corporation Fab i inhibitors
PE20010635A1 (es) 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
US6503908B1 (en) 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds
US6656703B1 (en) 1999-12-29 2003-12-02 Millennium Pharamaceuticals, Inc. High throughput screen for inhibitors of fatty acid biosynthesis in bacteria
US6372752B1 (en) 2000-02-07 2002-04-16 Genzyme Corporation Inha inhibitors and methods of use thereof
HUP0400651A2 (hu) 2000-11-07 2004-06-28 Bristol-Myers Squibb Company Szerin proteáz inhibitorokként alkalmazható savszármazékok és ezeket tartalmazó gyógyszerkészítmények
US20020107266A1 (en) 2000-12-12 2002-08-08 Marguerita Lim-Wilby Compounds, compositions and methods for treatment of parasitic infections

Also Published As

Publication number Publication date
WO2000072846A1 (en) 2000-12-07
CA2375630A1 (en) 2000-12-07
AR024158A1 (es) 2002-09-04
KR20020005767A (ko) 2002-01-17
BR0011121A (pt) 2002-02-26
HK1045644A1 (zh) 2002-12-06
US6573272B1 (en) 2003-06-03
ZA200109733B (en) 2002-09-11
US6964970B2 (en) 2005-11-15
NZ515611A (en) 2004-05-28
DE60016198T2 (de) 2005-12-01
CO5370679A1 (es) 2004-02-27
CZ20014290A3 (cs) 2002-05-15
EP1180030B1 (en) 2004-11-24
IL146514A0 (en) 2002-07-25
CN1365280A (zh) 2002-08-21
JP2003500448A (ja) 2003-01-07
HUP0201206A3 (en) 2003-07-28
HUP0201206A2 (en) 2002-08-28
AU773550B2 (en) 2004-05-27
PL351959A1 (en) 2003-07-14
AU5177400A (en) 2000-12-18
DE60016198D1 (de) 2004-12-30
EP1180030A1 (en) 2002-02-20
EP1180030A4 (en) 2002-09-25
JP4733836B2 (ja) 2011-07-27
MXPA01012326A (es) 2002-07-30
TR200103485T2 (tr) 2002-04-22
ATE283049T1 (de) 2004-12-15
NO20015722D0 (no) 2001-11-23
US20030232850A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
EE200100502A (et) Ühendid
ATE344248T1 (de) Antibakterielle verbindungen
NO20015722D0 (no) Antibakterielle forbindelser
PT1202994E (pt) Novos compostos
PT1206469E (pt) Fenil-oxazolidinonas substituidas heterociclicas antibacterianas
EE200200224A (et) Uudsed ühendid
NO20016115D0 (no) Substituerte heterocykelkondenserte gamma-karboliner
DE60006227D1 (de) Antimikrobielle gegenstände
IS6139A (is) Ný efnasambönd
NO20020621D0 (no) Antibakterielle midler
DE60102936D1 (de) Antibakterielle mutiline
ID29533A (id) Senyawa-senyawa kalsilitik
NO20020466L (no) Kalsilytiske forbindelser
IS6141A (is) Ný efnasambönd
NO20014262D0 (no) Tiazoloindolinon-forbindelser
ID29984A (id) Senyawa-senyawa bis-stirilbifenil
DE50003921D1 (de) Substituierte phenyluracile
SE9903838D0 (sv) Novel compounds
SE9901271D0 (sv) Novel compounds
SE9901078D0 (sv) Novel compounds
SE9901117D0 (sv) Novel compounds
SE9901118D0 (sv) Novel compounds
SE9901270D0 (sv) Novel compounds
SE9902194D0 (sv) Novel compounds
SE9902764D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application